BR0311201A - Método para induzir a expressão de uma sequência de nucleotìdeos de interesse em uma célula eucariótica, sequência de nucleotìdeos isolada, proteìna de fusão reguladora, célula eucariótica, animal transgênico, e, método para controlar a produção de um produto de uma sequência de nucleotìdeos de interesse em uma célula eucariótica - Google Patents

Método para induzir a expressão de uma sequência de nucleotìdeos de interesse em uma célula eucariótica, sequência de nucleotìdeos isolada, proteìna de fusão reguladora, célula eucariótica, animal transgênico, e, método para controlar a produção de um produto de uma sequência de nucleotìdeos de interesse em uma célula eucariótica

Info

Publication number
BR0311201A
BR0311201A BR0311201-2A BR0311201A BR0311201A BR 0311201 A BR0311201 A BR 0311201A BR 0311201 A BR0311201 A BR 0311201A BR 0311201 A BR0311201 A BR 0311201A
Authority
BR
Brazil
Prior art keywords
interest
nucleotide sequence
eukaryotic cell
sequence
product
Prior art date
Application number
BR0311201-2A
Other languages
English (en)
Other versions
BRPI0311201B1 (pt
BRPI0311201B8 (pt
Inventor
James P Fandl
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of BR0311201A publication Critical patent/BR0311201A/pt
Publication of BRPI0311201B1 publication Critical patent/BRPI0311201B1/pt
Publication of BRPI0311201B8 publication Critical patent/BRPI0311201B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/15Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/42Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MéTODO PARA INDUZIR A EXPRESSãO DE UMA SEQuêNCIA DE NUCLEOTìDEOS DE INTERESSE EM UMA CéLULA EUCARIóTICA, SEQuêNCIA DE NUCLEOTìDEOS ISOLADA, PROTEìNA DE FUSãO REGULADORA, CéLULA EUCARIóTICA, ANIMAL TRANSGêNICO, E, MéTODO PARA CONTROLAR A PRODUçãO DE UM PRODUTO DE UMA SEQuêNCIA DE NUCLEOTìDEOS DE INTERESSE EM UMA CéLULA EUCARIóTICA". Composições e métodos para a expressão indutível de genes em células eucarióticas. A expressão de uma seq³ência de interesse é controlada por uma proteína de fusão reguladora que consiste de um domínio de bloqueio da transcrição e um domínio de ligação por ligando. Quando o ligando cognato para o domínio de ligação por ligando está presente, a transcrição da seq³ência de nucleotídeos de interesse é bloqueada. Após a remoção do ligando cognato, a seq³ência de nucleotídeos de interesse é transcrita. O método é útil para a produção em larga escala de um produto desejado em células eucarióticas.
BRPI0311201-2A 2002-05-29 2003-05-28 A method for inducing the expression of a nucleotide sequence of interest in a eukaryotic cell, a regulatory fusion protein, and a method for controlling the production of a product of a nucleotide sequence of interest in a eukaryotic cell BRPI0311201B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38400402P 2002-05-29 2002-05-29
US60/384,004 2002-05-29
PCT/US2003/016676 WO2003101189A1 (en) 2002-05-29 2003-05-28 Inducible eukaryotic expression system

Publications (3)

Publication Number Publication Date
BR0311201A true BR0311201A (pt) 2005-02-22
BRPI0311201B1 BRPI0311201B1 (pt) 2017-08-08
BRPI0311201B8 BRPI0311201B8 (pt) 2021-05-25

Family

ID=29711966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0311201-2A BRPI0311201B1 (pt) 2002-05-29 2003-05-28 A method for inducing the expression of a nucleotide sequence of interest in a eukaryotic cell, a regulatory fusion protein, and a method for controlling the production of a product of a nucleotide sequence of interest in a eukaryotic cell

Country Status (11)

Country Link
US (2) US7455988B2 (pt)
EP (1) EP1531666B1 (pt)
JP (2) JP4817657B2 (pt)
AU (1) AU2003237259B2 (pt)
BR (1) BRPI0311201B1 (pt)
CA (1) CA2485939C (pt)
DK (1) DK1531666T3 (pt)
ES (1) ES2439874T3 (pt)
HK (1) HK1075364A1 (pt)
MX (1) MXPA04011679A (pt)
WO (1) WO2003101189A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322771A2 (en) * 2000-09-09 2003-07-02 BASF Plant Science GmbH MODIFIED i TET /i -INDUCIBLE SYSTEM FOR REGULATION OF GENE EXPRESSION IN PLANTS
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
CA2543257C (en) 2003-10-24 2013-12-31 Gencia Corporation Methods and compositions for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
GB0418651D0 (en) * 2004-08-20 2004-09-22 Medical Res Council Method
IN2014DN06624A (pt) * 2005-10-18 2015-07-10 Univ Colorado
DK2393927T3 (en) 2009-02-09 2015-03-30 Morphosys Ag Preparation of oligoclonal mixtures of antibodies in the individual cells
TWI641687B (zh) 2012-05-29 2018-11-21 美商再生元醫藥公司 生產細胞株增強子
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
CN104211814A (zh) 2013-05-29 2014-12-17 三星电子株式会社 用于消耗靶膜蛋白的组合物
TW202330904A (zh) 2015-08-04 2023-08-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
EP3411483B1 (en) * 2016-02-05 2022-07-06 PolyGene AG Glucocorticoid-based gene regulation system
SG10202010155YA (en) 2016-04-20 2020-11-27 Regeneron Pharma Compositions and methods for making antibodies based on use of expression-enhancing loci
MX2018012866A (es) 2016-04-20 2019-03-11 Regeneron Pharma Composiciones y metodos para generar anticuerpos basado en el uso de un locus potenciador de la expresion.
EP4320228A1 (en) * 2021-04-06 2024-02-14 Senti Biosciences, Inc. Ert2 mutants and uses thereof
WO2022216825A1 (en) * 2021-04-06 2022-10-13 Senti Biosciences, Inc. Ert2 mutants and uses thereof
MX2024004691A (es) * 2021-10-18 2024-05-23 Regeneron Pharma Transcripcion controlada de polinucleotidos.
US20230287043A1 (en) 2022-03-02 2023-09-14 Regeneron Pharmaceuticals, Inc. Cell culture methods for antibody production

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833080A (en) * 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US5866755A (en) * 1993-06-14 1999-02-02 Basf Aktiengellschaft Animals transgenic for a tetracycline-regulated transcriptional inhibitor
US5814618A (en) * 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
AU684524B2 (en) * 1993-06-14 1997-12-18 Tet Systems Holding Gmbh & Co. Kg Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
GB2301991B (en) * 1995-06-06 1999-06-30 Plessey Telecomm SDH Network
US6133027A (en) * 1996-08-07 2000-10-17 City Of Hope Inducible expression system
US5739018A (en) * 1996-08-07 1998-04-14 The Regents Of The University Of California Packaging cell lines for pseudotyped retroviral vectors
US5972650A (en) * 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
CA2300376A1 (en) * 1997-08-26 1999-03-04 Ariad Gene Therapeutics, Inc. Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
US6153383A (en) * 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
FR2782732A1 (fr) * 1998-08-28 2000-03-03 Transgene Sa Systeme d'expression inductible
US7329728B1 (en) 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
FR2814642B1 (fr) * 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
AU2002253836A1 (en) * 2000-10-20 2002-08-19 Canji, Inc Aptamer-mediated regulation of gene expression
US20040102367A1 (en) * 2001-02-23 2004-05-27 Gage Fred H Gene expression system based on chimeric receptors
US7153685B2 (en) * 2002-03-11 2006-12-26 The Board Of Trustees Of The University Of Illinois Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells

Also Published As

Publication number Publication date
WO2003101189A1 (en) 2003-12-11
JP2011152152A (ja) 2011-08-11
US7455988B2 (en) 2008-11-25
EP1531666A1 (en) 2005-05-25
DK1531666T3 (da) 2014-01-13
AU2003237259B2 (en) 2008-01-24
JP2005527227A (ja) 2005-09-15
US7514545B2 (en) 2009-04-07
BRPI0311201B1 (pt) 2017-08-08
ES2439874T3 (es) 2014-01-27
JP4817657B2 (ja) 2011-11-16
MXPA04011679A (es) 2005-03-07
CA2485939C (en) 2013-10-29
EP1531666B1 (en) 2013-10-23
AU2003237259A1 (en) 2003-12-19
US20030235886A1 (en) 2003-12-25
US20060107341A1 (en) 2006-05-18
EP1531666A4 (en) 2006-05-24
BRPI0311201B8 (pt) 2021-05-25
HK1075364A1 (en) 2005-12-16
CA2485939A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
BR0311201A (pt) Método para induzir a expressão de uma sequência de nucleotìdeos de interesse em uma célula eucariótica, sequência de nucleotìdeos isolada, proteìna de fusão reguladora, célula eucariótica, animal transgênico, e, método para controlar a produção de um produto de uma sequência de nucleotìdeos de interesse em uma célula eucariótica
Kumar et al. Dynamics of DNA methylation and its functions in plant growth and development
Bemer et al. Dynamic regulation of Polycomb group activity during plant development
Schubert et al. Epigenetic control of plant development by Polycomb-group proteins
Ojolo et al. Regulation of plant growth and development: a review from a chromatin remodeling perspective
Pien et al. Polycomb group and trithorax group proteins in Arabidopsis
Kim et al. Chromatin changes in response to drought, salinity, heat, and cold stresses in plants
Rodrigues et al. Evolution and function of genomic imprinting in plants
Lauria et al. Epigenetic control of gene regulation in plants
He et al. Regulation and function of DNA methylation in plants and animals
Wang et al. Epigenetic processes in flowering plant reproduction
Wollmann et al. Epigenetic reprogramming during plant reproduction and seed development
Feng et al. Epigenetic modifications in plants: an evolutionary perspective
Jiang et al. Evolution, function, and regulation of genomic imprinting in plant seed development
Borg et al. Histone variants take center stage in shaping the epigenome
Deal et al. Histone variants and modifications in plant gene regulation
Baroux et al. The maternal to zygotic transition in animals and plants
Martínez et al. Developmental relaxation of transposable element silencing in plants: functional or byproduct?
Köhler et al. Epigenetic inheritance of expression states in plant development: the role of Polycomb group proteins
Huh et al. Endosperm gene imprinting and seed development
Ikeda et al. DNA demethylation: a lesson from the garden
She et al. Chromatin dynamics during plant sexual reproduction
Feng et al. LHP1 could act as an activator and a repressor of transcription in plants
Grimanelli et al. Epigenetics and development in plants: green light to convergent innovations
Vigneau et al. The epigenetic origin of life history transitions in plants and algae

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A01K 67/00 , C07K 19/00 , C12N 5/10 , C12N 15/79 , C12P 21/02

Ipc: C12N 5/10 (2006.01), C12N 5/07 (2010.01), C12N 15/

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/05/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22E Other requirements [chapter 22.5 patent gazette]

Free format text: FORMULADA EXIGENCIA PARA ADEQUACAO OU CUMPRIMENTO DE DISPOSICOES LEGAIS NO PRAZO DE 60 (SESSENTA) DIAS DESTA DATA.